Edwards Lifesciences

American medical technology company

EW NYSE ISIN US28176E1082 SEC CIK 1099800 LEI YA13X31F3V31L8TMPR58
Follow Edwards Lifesciences Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.7B +10.5% vs same quarter last year
Net income $307.5M +5.6% vs same quarter last year
EPS, diluted $0.53 +6% vs same quarter last year
Operating cash flow $570.3M −0.6% vs same quarter last year
Revenue by quarter
$1.4B
$1.4B
$1.5B
$1.6B
$1.6B
$1.6B
$1.7B
$1.7B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$2B$4B$6B$8BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$6.1B$1.1B
FY24$5.4B$4.2B
FY23$5B$1.4B
FY22$4.5B$1.5B
FY21$5.2B$1.5B
FY20$4.4B$823.4M
FY19$4.3B$1B
FY18$3.7B$722.2M
FY17$3.4B$583.6M
FY16$3B$569.5M
FY15$2.5B$494.9M
FY14$2.3B$811.1M
FY13$2B$389.1M
FY12$1.9B$291.5M
FY11$1.7B$236.7M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2578%20.8%17.7%
FY2479.5%25.3%76.7%
FY2380.5%26.1%28%
FY2283.8%33.6%34.1%
FY2176.1%32.3%28.7%
FY2075.4%20.5%18.8%
FY1974.4%26.4%24.1%
FY1874.8%20.1%19.4%
FY1774.5%31.7%17%
FY1673.1%25.3%19.2%
FY1575.2%-19.8%
FY1473.1%-34.9%
FY1374.7%-19%
FY1274.2%-15.3%
FY1170.8%-14.1%
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.3B
FY24$289.9M
FY23$642.8M
FY22$973.6M
FY21$1.4B
FY20$647.3M
FY19$928.5M
FY18$688M
FY17$832.6M
FY16$528.3M
FY15$447M
FY14$939.4M
FY13$363.7M
FY12$253.1M
FY11$231.6M
Returned to shareholdersDividends paid and shares bought back
$0$500M$1B$1.5B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$893.4M
FY24$1.2B
FY23$879.6M
FY22$1.7B
FY21$512.8M
FY20$625.4M
FY19$263.3M
FY18$795.5M
FY17$763.3M
FY16$662.3M
FY15$280.1M
FY14$300.9M
FY13$496.9M
FY12$344.1M
FY11$303.4M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Edwards Lifesciences
  • Healthcare median
−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearEdwards LifesciencesHealthcare median
FY2517.7%−30.6%
FY2476.7%−47%
FY2328%−58%
FY2234.1%−80.4%
FY2128.7%−71.9%
FY2018.8%−62.2%
FY1924.1%−46.3%
FY1819.4%−49.6%
FY1717%−45.9%
FY1619.2%−36%
FY1519.8%−38.4%
FY1434.9%−35.5%
FY1319%−37.1%
FY1215.3%−29.1%
FY1114.1%−27.9%